Literature DB >> 11920288

Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.

Susan T Goldstein1, Miriam J Alter, Ian T Williams, Linda A Moyer, Franklyn N Judson, Karen Mottram, Michael Fleenor, Patricia L Ryder, Harold S Margolis.   

Abstract

From 1982-1998, enhanced sentinel surveillance for acute hepatitis B was conducted in 4 counties in the United States to determine trends in disease incidence and risk factors for infection. During this period, the reported incidence of acute hepatitis B declined by 76.1% from 13.8 cases per 100,000 in 1987 to 3.3 cases per 100,000 in 1998. Cases associated with injection drug use (IDU) decreased by 90.6%, men who have sex with men (MSM) by 63.5%, and heterosexual activity by 50.7%. During 1994-1998, the most commonly reported risk factor for infection was high-risk heterosexual activity (39.8%) followed by MSM activity (14.6%) and IDU (13.8%). Over half of all patients (55.5%) reported treatment for a sexually transmitted disease (STD) or incarceration in a prison or jail prior to their illness, suggesting that more than half of the acute hepatitis B cases might have been prevented through routine hepatitis B immunization in STD clinics and correctional health care programs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920288     DOI: 10.1086/339192

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

1.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

Review 2.  Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Authors:  Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

3.  Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18-49 Years With Risk Factors for Hepatitis B Virus Infection-United States, 2003-2014.

Authors:  Hope King; Jian Xing; Hazel D Dean; Deborah Holtzman
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

4.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

5.  Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.

Authors:  David Widjaja; Suresh Yarlagadda; Bheema S Singu; Raghu S Loganathan; Steve Blum; Alan Bloom; Prospere Remy
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

6.  Surveillance programs for chronic viral hepatitis in three health departments.

Authors:  Douglas T Fleming; Amy Zambrowski; Felicia Fong; Andrea Lombard; Lynne Mercedes; Claudia Miller; Jan Poujade; Aaron Roome; Amy Sullivan; Lyn Finelli
Journal:  Public Health Rep       Date:  2006 Jan-Feb       Impact factor: 2.792

7.  Epidemiology of hepatitis B virus infection in Albania.

Authors:  Bashkim Resuli; Skerdi Prifti; Bledar Kraja; Tatjana Nurka; Mimoza Basho; Edita Sadiku
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

8.  Adherence to hepatitis B virus vaccination at syringe exchange sites.

Authors:  Frederick L Altice; Robert D Bruce; Mary R Walton; Marta I Buitrago
Journal:  J Urban Health       Date:  2005-03-03       Impact factor: 3.671

9.  The Young Men's Survey phase II: hepatitis B immunization and infection among young men who have sex with men.

Authors:  Cindy M Weinbaum; Rob Lyerla; Duncan A Mackellar; Linda A Valleroy; Gina M Secura; Stephanie K Behel; Trista Bingham; David D Celentano; Beryl A Koblin; Marlene Lalota; Douglas A Shehan; Hanne Thiede; Lucia V Torian
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

Review 10.  Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications.

Authors:  Shaili Gupta; Frederick L Altice
Journal:  J Urban Health       Date:  2009-01-28       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.